From the Institute for Molecular Bioscience, University of Queensland, Brisbane, 4072 Queensland, Australia
Received for publication, February 22, 2001, and in revised form, April 2, 2001
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Much interest has been generated by recent
reports on the discovery of circular (i.e. head-to-tail
cyclized) proteins in plants. Here we report the
three-dimensional structure of one of the newest such circular
proteins, MCoTI-II, a novel trypsin inhibitor from Momordica cochinchinensis, a member of the Cucurbitaceae
plant family. The structure consists of a small Over the last few years a number of small disulfide-rich proteins
that have a head-to-tail cyclized peptide backbone have been discovered
in plants. These circular proteins include kalata B1 (1), the circulins
(2, 3), and cyclopsychotride A (4) from the Rubiaceae family, and
various peptides from plants in the Violaceae family (3, 5-8). They
contain ~30 amino acids, including six highly conserved cysteine
residues that form three structurally important disulfide bonds. The
latter contribute to the molecules having well defined and stable
three-dimensional structures (8). Because of their well defined
structures and potent biological activities, the molecules may be
regarded as miniproteins. We recently proposed that the known circular
proteins most likely form part of a large family of proteins that we
refer to as the plant cyclotides (8). They contain the conserved cysteine spacing
CX3-CX4-CX4-7-CX1-CX4-5-CX5-7 within their circular backbone.
The plant cyclotides display a diverse range of biological activities
ranging from uterotonic action (kalata B1 (1)), to anti-HIV activity
(circulins (2)), to hemolytic activity (5, 9, 10), and inhibition of
neurotensin binding (cyclopsychotride A (4)). Although their precise
role in plants has not yet been reported, it appears that they are most
likely present as defense molecules. All of their biological activities
in mammalian systems seem to be related in one way or another to
membrane interactions, a common feature of plant defense molecules.
Recently the cyclotides have also been reported to display a wide range
of anti-microbial activities against Gram-positive and Gram-negative
bacteria, and against certain fungi (9), further enhancing the
likelihood that they are indeed plant defense molecules.
The three-dimensional structures of three members of the plant
cyclotide family have now been determined, including the prototypic member kalata B1, the first macrocyclic peptide for which a full three-dimensional structure was determined (1), circulin A (11), and
cycloviolacin O1 (8). The structures are all highly conserved and
contain a distorted triple stranded Recently Hernandez et al. (16) reported two new macrocyclic
peptides derived from Momordica cochinchinensis, a vine
plant from the Cucurbitaceae plant family. The two molecules, named MCoTI-I and MCoTI-II are trypsin inhibitors and comprise 34 amino acids, a cyclized peptide backbone, and three disulfide bonds. They are
homologous to a large range of open-chain trypsin inhibitors from
plants (16), but are the first reported macrocyclic trypsin inhibitors
(although note that a smaller, single disulfide-containing cyclic
trypsin inhibitor was recently reported from sunflower seeds (17)).
This exciting discovery supports our view that macrocyclic peptides are
much more common in plants than has previously been realized, and that
many more are likely to be discovered over coming years.
The sequences of the two new trypsin inhibitors, MCoTI-I and MCoTI-II,
show little homology with the known plant cyclotides apart from the
six-conserved cysteine residues and the macrocyclic peptide backbone,
as seen by a comparison of MCoTI-II and kalata B1 in Fig.
1. Note that because the molecules are
cyclic the choice of numbering of residue 1 is arbitrary but throughout
the text we have adopted the numbering scheme used by Hernandez
et al. (16). In addition, we adopted our earlier
nomenclature for defining the six cysteine residues (labeled I-VI) and
the six backbone loops that make up the sequences between the cysteine
residues (loops 1-6). This numbering scheme is defined in Fig. 1.
-sheet, several
turns, and a cystine knot arrangement of the three disulfide bonds.
Interestingly, the molecular topology is similar to that of the plant
cyclotides (Craik, D. J., Daly, N. L., Bond, T., and Waine,
C. (1999) J. Mol. Biol. 294, 1327-1336), which derive from
the Rubiaceae and Violaceae plant families, have antimicrobial
activities, and exemplify the cyclic cystine knot structural
motif as part of their circular backbone. The sequence, biological
activity, and plant family of MCoTI-II are all different from known
cyclotides. However, given the structural similarity, cyclic backbone,
and plant origin of MCoTI-II, we propose that MCoTI-II can be
classified as a new member of the cyclotide class of proteins. The
expansion of the cyclotides to include trypsin inhibitory activity and
a new plant family highlights the importance and functional variability
of circular proteins and the fact that they are more common than has
previously been believed. Insights into the possible roles of backbone
cyclization have been gained by a comparison of the structure of
MCoTI-II with the homologous acyclic trypsin inhibitors CMTI-I and
EETI-II from the Cucurbitaceae plant family.
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-sheet, perhaps better described
as a well defined
-hairpin with a third strand forming a
-bulge
(8). The three disulfide bonds are arranged in a so called cystine
knot, in which an embedded ring in the structure formed by two
disulfide bonds and their connecting backbone segments forms a ring
that is penetrated by the third disulfide bond (12-15). Although a
seemingly unlikely structural motif, the cystine knot has now been seen
in a variety of small disulfide-rich proteins from both the plant and
animal kingdoms (15), and seems to be associated with exceptionally
high stability and resistance to proteolytic cleavage of molecules
containing it. This is particularly so for the cyclotides, which
contain a cyclic cystine knot motif (8).
View larger version (14K):
[in a new window]
Fig. 1.
Sequence alignment of MCoTI-II with kalata
B1. The disulfide connectivities are represented at the
top of the diagram and the -sheet regions of kalata B1
are represented as arrows. Cysteine residues are numbered by
Roman numerals. The loops (regions between successive Cys
residues) are numbered at the bottom of the diagram based on
the numbering scheme previously used for kalata B1 (8). The numbering
scheme used for MCoTI-II throughout the text is based on the paper
describing the isolation of this peptide (16). Residue 1 for this
numbering scheme is shown on the sequence of MCoTI-II.
The three-dimensional structure of MCoTI-II has been modeled (16) based on its sequence similarity to open chain trypsin inhibitors, however, no experimental determination of the three-dimensional structure of the new macrocyclic peptides is available. We were interested to see whether this class was similar to the plant cyclotides and contained the cystine knot motif. We therefore isolated and purified a sample of MCoTI-II from M. cochinchinensis and herewith report the three-dimensional structure determined using NMR spectroscopy and simulated annealing calculations.
One of the motivating factors for examining structures of this class of
molecules is that they are known to be highly stable and, indeed, in
the case of kalata B1, are apparently orally bioavailable, a most
unusual feature for peptide-based molecules. This bioavailability is
demonstrated in the native medicine applications of Oldenlandia affinis, the plant from which kalata B1 is derived. Women of
certain tribes in the Congo region ingest a tea made from the plant to accelerate labor (18). The possibility of using the cyclic cystine knot
macrocyclic disulfide knotted framework as a template in pharmaceutical
design applications is thus very attractive (19). The three-dimensional
structure reported here provides a basis for these applications, as
well as demonstrating that the new trypsin inhibitors form part of the
cyclotide family.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Isolation and Purification of MCoTIs-- Ripe frozen fruits of M. cochinchinensis were purchased from a Vietnamese store in Melbourne, Australia. The dormant seeds were homogenized using a blender and extracted with 20 mM sodium acetate. The fine debris was removed using a cotton plug. 40% Acetone, H2O (v/v) solution was added to the crude extract at a ratio of ~1:1 (v/v). Acetone was reduced using a rotary evaporator after which the mixture was cooled down to 4 °C and centrifuged for 30 min. The supernatant was then passed through a filter before purification using preparative RP-HPLC1 on a Vydac C18 column. Gradients of 0.1% aqueous trifluoroacetic acid and 90% acetonitrile, 0.09% trifluoroacetic acid were employed with a flow rate of 8 ml/min, and the eluant monitored at 230 nm. Further purification was performed using semipreparative RP-HPLC on a Vydac C18 column. The final purity was examined with analytical RP-HPLC and electrospray mass spectrometry.
NMR Spectroscopy--
Samples for 1H NMR
measurements contained 1 mM peptide in either 99.99%
D2O or 90% H2O, 10% D2O (v/v) at
pH 3.5. Spectra were recorded at 288, 293, and 298 K on a Bruker AVANCE
750 MHz spectrometer. The two-dimensional NMR experiments employed were
similar to those used for the related cyclic peptide circulin A (11)
and included DQF-COSY, E-COSY, and TOCSY using a MLEV-17 spin lock
sequence with a mixing time of 80 ms, and NOESY with mixing times of
150, 200, 250, and 300 ms. Slowly exchanging NH protons were detected by acquiring a series of one-dimensional and TOCSY spectra of the fully
protonated peptide immediately following dissolution in
D2O.
3JH-
H
coupling constants were measured from E-COSY spectra and
3JNH-
H coupling
constants were measured from DQF-COSY spectra, transformed over the
fingerprint region to 8 × 1 K. Spectra were processed according
to methods given in Daly et al. (11). Chemical shifts were
referenced to sodium 2,2-dimethyl-2-silapentane-5-sulfonate at 0.00 ppm
and the spectra were analyzed and assigned using XEASY (20).
Structural Restraints--
Peak volumes were integrated using
XEASY and distance restraints obtained from CALIBA with appropriate
pseudoatom corrections. Backbone dihedral restraints were inferred from
3JNH-H coupling
constants, with
restrained to 120 ± 30° for a
3JNH-
H greater than 9 Hz, and 65 ± 30° for a
3JNH-
H less than 6 Hz. Stereospecific assignments and
1 angle restraints
were obtained for 7 residues using coupling constants measured in an
ECOSY spectrum in conjunction with NOE intensities. Both proline
residues were in the trans-conformation based on characteristic NOEs.
The
-methylene protons of the proline residues were
stereospecifically assigned based on the peak intensities in the NOESY
spectra. Six hydrogen bonds were determined based on slow exchange data
and preliminary structure calculations. Hydrogen bond restraints of
1.7-2.2 and 2.7-3.2 Å were used for the
HNi-Oj and Ni-Oj
distances, respectively.
Structure Calculations--
Three-dimensional structures were
initially calculated using DYANA (21) to check NOE restraints for
violations and resolve ambiguous cross-peaks. Dihedral angle and
hydrogen bond restraints were subsequently included in these structure
calculations. The final 50 structures were generated using a torsion
angle dynamics protocol (22, 23) within the program X-PLOR 3.851 (24). Refinement of these structures was achieved using the conjugate gradient Powell algorithm with 1000 cycles of energy minimization (25)
in a refined forcefield based on the program CHARMm (26). Structures
were analyzed using PROMOTIF (27) and PROCHECK-NMR (28).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The seeds of M. cochinchinensis were extracted with
sodium acetate as described previously (16) and the extract was
purified using RP-HPLC. Various peptides were isolated and their
molecular weights were analyzed by mass spectrometry. Molecular weights consistent with the previously isolated macrocyclic peptides, MCoTI-I
(3480) and MCoTI-II (3453), were present in addition to isomers
corresponding to the -aspartyl (3453) and succinimide (3435.5) forms
of MCoTI-II (16). In the previous study (16) the peptide bond between
Asp-4 and Gly-5 was shown to be susceptible to succinimide and
-aspartyl formation and this was confirmed in the current study.
Sufficient quantities of MCoTI-II and its -aspartyl isomer were
isolated to allow characterization with NMR spectroscopy. Amino acid
sequencing was performed essentially using NMR spectroscopy, as the
spin systems observed in TOCSY spectra and the sequential connectivities observed in NOESY spectra were completely consistent with those of the published sequence (16). Assignments were made using
established techniques (29) and the 1H chemical shifts are
supplied as supplementary material. The fingerprint regions of a TOCSY
and NOESY spectra of MCoTI-II are given in Fig.
2. The amide region is very well
dispersed and this facilitated the assignment process. The excellent
dispersion and large number of cross-peaks in the NOESY spectrum also
provided the first indication of a well defined three-dimensional
structure.
|
As the -aspartyl homologue of MCoTI-II has an identical molecular
weight to the normal (
-aspartyl) isomer, NMR spectroscopy was used
to discriminate between these molecules. Only one form (i.e.
that eluting later on HPLC) displayed the expected sequential NOE
connectivities (Fig. 3a)
between residues 4 and 5, which strongly suggests this form contains
the "normal" peptide backbone. Comparison of the
H chemical
shifts of both isomers (Fig. 3b) suggests that the molecules
have very similar structures, with the exception of the region
surrounding residues 4 and 5. Having established the similarity of the
two forms, in the current study we have determined the
three-dimensional structure of the isomer of MCoTI-II with the
-Asp-4 configuration.
|
Analysis of the NOE data, coupling constants and slow exchange amide
protons (Fig. 4a) allowed the
secondary structure to be elucidated as shown in Fig. 4b. A
-hairpin is present within residues 26-34 and there are
-sheet
interactions between this hairpin and residues 13-15. An analysis of
secondary shifts (i.e. the differences between observed
chemical shifts and random coil values (30)) supported this
interpretation of the secondary structure and indicated the presence of
-strands but no helical regions.
|
The three-dimensional structure of MCoTI-II was determined using
torsion angle dynamics coded within the program XPLOR (24). The
disulfide bonding pattern had not been determined chemically and so it
was important to define this using NMR methods. For small
disulfide-rich molecules in which the disulfide bonds form a compact
core such an approach is often the only one available due to the
difficulty of obtaining suitable cleavage products. Preliminary
structure calculations without any disulfide bonds included as
restraints were consistent with the disulfide connectivities being
identical to those in linear squash trypsin inhibitors (31) previously
characterized and those in the cyclotide peptides (8) (i.e.
Cys I-Cys IV, Cys II-Cys V, and Cys III-Cys VI). This conclusion was
based on an analysis of distances between all possible pairs of S atoms
in the preliminary structures (Supplementary Material). This clearly
shows that the optimal S-S pairing corresponds to the Cys I-Cys IV, Cys
II-Cys V, and Cys III-Cys VI connectivity. Subsequent structure
calculations were performed with the disulfide bonds formally connected
in this way and these yielded structures of low energy and excellent
covalent geometry. Combined with the consistency with the homologous
squash inhibitors and the plant cyclotides this was taken as strong
evidence for the proposed disulfide connectivity. Hydrogen bonds were
also inferred from the preliminary structure calculations in
conjunction with the slow exchange data, and all were consistent with
the -sheet shown in Fig. 4b.
The family of structures for MCoTI-II is well defined over most of the
molecule (residues 8-34), however, there are few medium or long range
NOEs for the first seven residues and this results in a lack of
definition in this region (Fig.
5a). This is reflected in the
angular order parameters (Supplementary Material) that are generally
>0.9 for the and
angles for residues 8-34, but vary between
0.2 and 0.9 for residues 1-7. Geometric and energetic statistics that
define the 20 lowest energy structures are given as supplementary data.
The RMSD's for residues 8-34 are 0.70 ± 0.17 and 1.86 ± 0.38 Å for the backbone atoms and all heavy atoms, respectively. The
corresponding values are 0.45 ± 0.11 and 1.56 ± 0.22 Å for
superimposition over residues 12-34.
|
The major features of the three-dimensional structure are a -sheet
region and several turns. Analysis of the secondary structure elements
in the final family of calculated structures with PROMOTIF (27) reveals
a
turn between residues 18 and 20 and
-turns between residues
15-18 and 22-25. A
-hairpin is formally recognized by PROMOTIF
between residues 26 and 34, as expected from the preliminary secondary
structure analysis, and a type I
-turn between residues 28 and 31 connects the strands. The
-sheet interactions observed between the
hairpin and residues 13-15 (Fig. 4b) are not formally recognized by PROMOTIF as part of a triple-stranded
-sheet. However, this is also found for other related small disulfide-rich peptides and
is hence not surprising. In the plant cyclotides (19) the third
-strand is only loosely connected to the well defined
-hairpin. Thus, despite the presence of NOEs and slowly exchanging amide protons
characteristic of
-sheets, the orientations of the strands in the
structure calculations are such that they are not formally recognized
as part of a triple-stranded
-sheet in all of the structures.
The disulfide bonds of MCoTI-II form a cystine knotted structure similar to that in the plant cyclotides. In this arrangement the embedded ring formed by Cys I-Cys IV and Cys II-Cys V and their connecting backbone segments is threaded by the third disulfide bond, Cys III-Cys VI. A schematic representation of the secondary structure and the cystine knot of MCoTI-II is given in Fig. 5b.
Since the peptide backbone of MCoTI-II is cyclic, a convenient way to
describe the structural features is in terms of the six segments, or
loops, that are flanked by pairs of successive Cys residues. Fig.
6 shows the backbone considered in this
way and highlights several features of the derived structures,
including the location of the three -strands and the various turns.
The disulfide bond connectivity is also shown. Loop 1, between Cys I
and Cys II contains a highly positively charged (+3) hexapeptide segment which, based on homology with corresponding acyclic trypsin inhibitors, comprises the putative active site residues Lys/Ile. Loop 2 contains two positive and two negative charges and includes a
-turn
between residues 15-18 and a
turn between residues 18 and 20. Loop
3 contains no charged residues but incorporates a
-turn within its
PGA sequence. Loop 4 contains a single amino acid (I) and is
incorporated within one of the
-strands that make up the
-hairpin. It is followed by loop 5, which contains a type I
-turn
and leads into loop 6, which incorporates the second strand of the
-hairpin. In the final folded structures the disulfide bonds
"pinch" the circular backbone and loops 2 and 5 are drawn very
close to one another.
|
Loop 6 protrudes from the structure more than any of the other loops
and is also the most disordered. Fig. 5 shows that individual structures vary widely in their placement of this loop relative to the
core of the molecule. This may reflect intrinsic flexibility or simply
a lack of NOEs defining this region. Loop 6 contains a high Gly content
and hence the number of possible protons, and hence NOEs, is reduced
relative to larger amino acids. To assess whether it was lack of NOEs,
or flexibility that results in the disorder for loop 6, the chemical
shift separation of the -protons of various amino acid side chains
was examined. In general, rigid conformations are associated with
widely separated
-proton shifts while, in contrast, degenerate
-proton shifts can be indicative of conformational averaging. For
example, in an analysis of acyclic permutants of kalata B1, those
permutants with decreased stability, based on amide exchange rates,
displayed a decreased shift dispersion for cysteine
-protons
(32).
Analysis of the -proton chemical shift separations for the six
cysteine residues of MCoTI-II supports the proposal of flexibility in
loop 6. The disulfide bond connecting residues 8 to 25 is the closest
disulfide bond to the disordered region and the
-protons are
essentially degenerate for both of these residues, suggesting conformational averaging in this region of the molecule. By contrast, the
-shifts for the remaining four cysteine residues are separated by 0.17 to 0.34 ppm and correspond to well defined regions of the
molecule. The flexibility in this putative linker region was predicted
in the model determined by Hernandez et al. (16). The model
also suggested contacts between Gly-6 and Ala-24, and indeed NOEs are
observed between these residues in our study. However, the possible
hydrogen bonding predicted between Ser-1 and Arg-28 was observed in
very few of the NMR structures.
A comparison of MCoTI-II with the trypsin inhibitor CMTI-I (31) and the
plant cyclotide, kalata B1, is given in Fig.
7. It is apparent the proteins possess
similar topologies. For example, the backbone atoms of the cysteine
residues of MCoTI-II and CMTI-I superimpose with an RMSD of 0.98 Å.
The equivalent RMSD for kalata B1 and MCoTI-II is much higher (6.02 Å)
because of the differences in spacings between the cysteine residues.
However, when superimposed over the backbone atoms of the four cysteine
residues that make up the ring of the cystine knot the RMSD value is
1.83 Å. Another trypsin inhibitor, EETI-II (33), also has a similar
structure to MCoTI-II and superimposes with an RMSD of 1.37 Å over the
backbone atoms of the cysteine residues.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the current study we have determined the three-dimensional
structure of MCoTI-II, a 34-amino acid trypsin inhibitor from M. cochinchinensis. It has the unusual feature of a head-to-tail cyclized peptide backbone, and thus joins the ranks of an increasing number of small circular proteins discovered over the last five years.
The main element of secondary structure is a -hairpin and associated
cystine knot framework. A third strand of
-sheet is loosely
connected with this hairpin and the molecule also contains several
turns. The overall fold is very similar to that of the squash trypsin
inhibitors EETI-II and CMTI-I. Both have high sequence homology with
MCoTI-II but are "conventional" proteins in that they lack the
head-to-tail cyclization of MCoTI-II.
The similarity of the overall fold of the cyclic inhibitor to those of linear homologues raises the question of what is the advantage/biological role of cyclization? Several possibilities could be contemplated, including factors relating to conformational or dynamic stabilization, changes in physicochemical properties, addition of new functionality, or protection from proteolytic cleavage. We examine these possibilities in turn and then compare this newly discovered cyclic plant protein with the previously reported cyclotide family (8) of macrocyclic knotted peptides.
Possible conformational effects of cyclization could include
stabilization of the active site residues into a preferred conformation for binding, or entropic stabilization associated with tethering the
ends of linear homologues. The termini of small peptides are often
disordered and hence contribute to unfavorable entropic losses on
binding to target proteins. Cyclization can potentially reduce such
losses by reducing mobility near the termini. However, this does not
seem to be the primary role of cyclization in the case of MCoTI-II,
since the putative linker involved in cyclization is in fact quite
flexible. While the gene coding for MCoTI-II has yet to be reported,
the mature peptide is likely to be derived from a larger precursor
protein, processing of which results in the ligation of N- and
C-terminal regions to form loop 6. This is based on analogy with the
gene for the related open chain peptide TGTI-II from Towel gourd (34),
whose sequence is consistent with loops 1-5 forming a contiguous
region of the peptide chain. From an entropic perspective it is
therefore surprising that the introduced loop 6 linker region is highly
disordered, and apparently flexible, in the cyclic protein. The
assumption that the disorder in this region reflects flexibility,
rather than simply a lack of NOEs is supported by an analysis of
chemical shift dispersion of -methylene protons.
Given that entropic factors do not explain the role of cyclization it
was of interest to see if there might be specific conformational changes associated with cyclization that are important in a static rather than dynamic sense, e.g. in stabilizing a particular
binding conformation. It has been suggested that the mechanism of
inhibition of the MCo peptides is identical to that for other squash
trypsin inhibitors, based on the sequence conservation in the putative inhibitory loop (16). The local conformations of the residues presumed
to be at the active site are summarized in Table
I for MCoTI-II and a range of linear
homologues, both in solution and complexed to trypsin. Comparison of a
linear squash inhibitor, CMTI-I (31), with the cyclic MCoTI-II reveals
similar backbone angles in solution, with the most significant
difference being in the angle of the P1 residue
(Lys-10) and to a lesser extent in the
angle of the P1'
residue. The solution structures of MCoTI-II and CMTI-I are also very
similar to the bound structures listed in Table I with the exception of
the
angle of the P1 residue. The lack of a major
conformational change between MCoTI-II and linear homologues, either in
solution or bound states, suggests that cyclization does not play a
significant role in determining the active site conformation.
|
The final inhibitor listed in Table I, sunflower trypsin inhibitor I
differs significantly from the others in that it is much smaller (14 residues), contains a single disulfide bond and unlike all except
MCoTI-II, is cyclic (17). It is a particularly potent trypsin inhibitor
despite this small size and hence provides an opportunity to assess the
essential residues for activity. Its three-dimensional structure in
complex with bovine -trypsin has been determined using x-ray
crystallography (17) and the active site residues are in similar
positions to those observed for the other squash inhibitors (Table I).
The fact that potent trypsin inhibition can be obtained with such a
small inhibitor is consistent with the fact that peripheral regions of
the MCoTI-II inhibitor are not essential for binding activity and
function, and hence play other roles. Conformational or entropic roles
for the loop 6 linker region have been discounted and hence factors relating to additional functionality or modulation of biophysical properties can be considered.
Another possible role for cyclization is that of protection from proteolytic cleavage. Indeed, based on the discussion above, which suggests that conformational or entropic roles are unlikely, this seems the most likely function of cyclization in MCoTI-II. Cyclization of small peptides is a well established method used in the pharmaceutical industry to protect small bioactive peptides against cleavage by in vivo exopeptidases. Being a seed component, the MCoTI-II peptide most likely has to survive intact for long periods prior to germination and its function would be compromised if broken down by exoproteases. MCoTI-II has also been shown to be resistant to the endoprotease thermolysin (16). This is analogous with the plant cyclotide, kalata B1, which is resistant to a range of enzymes including thermolysin, trypsin, and pepsin (1). In general the naturally occurring cyclization of macrocyclic peptides appears to be an effective means of stabilization, much as is the case for small synthetic peptides.
Kalata B1 is just one member of what is now a large family of cyclotides (8). Although MCoTI-II is of similar size (34 versus 29 amino acids) and cystine spacings, it displays no sequence homology to the previously identified plant cyclotides. Nevertheless, the three-dimensional structure is similar, and contains identical elements of secondary structure and the cystine knot motif. The combined presence of a cyclic peptide backbone and a cystine knot motif means that MCoTI-II fits into the cyclic cystine knot structural framework (8, 15). The structural similarity suggests the possibility that the cyclotides and the Momordica peptides may be evolutionarily related, despite the fact that they have different biological activities. Furthermore, the observation of different biological activities for the various members of the cyclotide family provides proof of the concept that the cyclic cystine knot framework is particularly stable and amenable to grafting of a range of different bioactivities (15).
Fig. 7 shows that the size of the cystine knot motif in the Momordica peptides is slightly different from those of the known cyclotides and that the embedded ring in the structure contains 11 amino acids rather than eight. This makes the cystine knot slightly looser, however, the derived family of structures are still very well defined over the core of the cystine knot. By contrast, the linker region associated with backbone cyclization appears much more flexible in the macrocyclic trypsin inhibitors than in the previously reported plant cyclotides. In the former case, the linker region consists of small hydrophilic amino acids, whereas in the plant cyclotides the residues are generally larger.
The previously reported cyclotides are characterized by their long
retention times on RP-HPLC. This is presumed to result from a patch of
surface-exposed hydrophobic residues (1). In the case of kalata B1 we
have shown that this patch arises after formation of the native
disulfide connectivities (10). The macrocyclic peptides from MCo elute
significantly earlier than the cyclotides, suggesting decreased
hydrophobicity. The MCo peptides also contain many more charged
residues, particularly positively charged residues, than the
cyclotides. The distribution of hydrophobic and charged residues for
MCoTI-II is shown in Fig. 8. Several of
the hydrophobic residues are surface exposed, presumably as a
consequence of the core of the molecule containing the disulfide bonds
and leaving very little room for other residues. These surface-exposed
hydrophobic residues appear mainly on one face of the molecule. The
other face of the molecule contains most of the positively and
negatively charged residues, with the positive residues clustered
together. Clustering of hydrophobic and cationic residues has
previously been found to be crucial for antimicrobial activity. The
distribution of these residues on the surface of MCoTI-II indicates
that such an activity may be possible for this molecule. This is
supported by the report that a preparation from M. cochinchinensis seeds, which contained mainly MCoTI-II, exhibited
antimicrobial properties (16).
|
An interesting difference between the previously reported cyclotides and the circular squash peptides is the absence of linear counterparts for the cyclotides. Linear squash inhibitors have been known for many years, however, so far there has been no evidence for linear forms of the cyclotides. This may be a consequence of the isolation techniques that have been employed to date, or may reflect highly efficient processing of the cyclotides from putative linear precursors. Despite these differences between MCoTI-II and the plant cyclotides the similar three-dimensional structure and cyclic backbone suggests they can be regarded as part of the same family of proteins. Thus the cyclotide family can be expanded to include the new cyclic trypsin inhibitors MCoTI-I and MCoTI-II.
This expansion of the cyclotide family to include trypsin inhibitors
from the Cucurbitaceae family highlights the importance and functional
variability of these peptides. The increasing incidence of discoveries
of naturally occurring circular proteins coincides with the excitement
currently associated with the use of intein-based methods for the
artificial production of circular proteins (35-38).
![]() |
ACKNOWLEDGEMENTS |
---|
We thank the Institute for Molecular Bioscience, a Special Research Center of the Australian Research Council.
![]() |
FOOTNOTES |
---|
* This work was supported in part by a grant from the Australian Research Council (to D. J. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1IB9) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
The on-line version of this article (available at
http://www.job.org) contains Tables 1-3 and Fig. 1.
Australian Research Council Senior Fellow. To whom correspondence
should be addressed: Institute for Molecular Bioscience, University of
Queensland, Brisbane, QLD 4072, Australia. Tel.: 61-7-3365-4945; Fax:
61-7-3365-2487; E-mail: d.craik@imb.uq.edu.au.
Published, JBC Papers in Press, April 5, 2001, DOI 10.1074/jbc.M101666200
![]() |
ABBREVIATIONS |
---|
The abbreviations used are: RP-HPLC, reversed-phase high performance liquid chromatography; MCo, Momordica cochinchinensis; TOCSY, two-dimensional total correlation spectroscopy; NOE, nuclear Overhauser effect; NOESY, two-dimensional NOE spectroscopy; DQF-COSY, double quantum filtered correlation spectroscopy; RMSD, root mean square deviation.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Saether, O., Craik, D. J., Campbell, I. D., Sletten, K., Juul, J., and Norman, D. G. (1995) Biochemistry 34, 4147-4158[Medline] [Order article via Infotrieve] |
2. | Gustafson, K. R., Sowder, R. C., II, Henderson, L. E., Parsons, I. C., Kashman, Y., Cardellina II, J. H., McMahon, J. B., Buckheit, R. W., Jr., Pannell, L. K., and Boyd, M. R. (1994) J. Am. Chem. Soc. 116, 9337-9338 |
3. | Gustafson, K. R., Walton, L. K., Sowder, R. C. I., Johnson, D. G., Pannell, L. K., Cardellina, J. H. I., and Boyd, M. R. (2000) J. Nat. Prod. 63, 176-178[CrossRef][Medline] [Order article via Infotrieve] |
4. | Witherup, K. M., Bogusky, M. J., Anderson, P. S., Ramjit, H., Ransom, R. W., Wood, T., and Sardana, M. (1994) J. Nat. Prod. 57, 1619-1625[Medline] [Order article via Infotrieve] |
5. | Schöpke, T., Hasan Agha, M. I., Kraft, R., Otto, A., and Hiller, K. (1993) Sci. Pharm. 61, 145-153 |
6. | Hallock, Y. F., Sowder, R. C. I., Pannell, L. K., Hughes, C. B., Johnson, D. G., Gulakowski, R., Cardellina, J. H. I., and Boyd, M. R. (2000) J. Org. Chem. 65, 124-128[CrossRef][Medline] [Order article via Infotrieve] |
7. | Göransson, U., Luijendijk, T., Johansson, S., Bohlin, L., and Claeson, P. (1999) J. Nat. Prod. 62, 283-286[CrossRef][Medline] [Order article via Infotrieve] |
8. | Craik, D. J., Daly, N. L., Bond, T., and Waine, C. (1999) J. Mol. Biol. 294, 1327-1336[CrossRef][Medline] [Order article via Infotrieve] |
9. |
Tam, J. P.,
Lu, Y. A.,
Yang, J. L.,
and Chiu, K. W.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8913-8918 |
10. | Daly, N. L., Love, S., Alewood, P. F., and Craik, D. J. (1999) Biochemistry 38, 10606-10614[CrossRef][Medline] [Order article via Infotrieve] |
11. | Daly, N. L., Koltay, A., Gustafson, K., R., Boyd, M. R., Casas-Finet, J. R., and Craik, D. J. (1999) J. Mol. Biol. 285, 333-345[CrossRef][Medline] [Order article via Infotrieve] |
12. | McDonald, N. Q., and Hendrickson, W. A. (1993) Cell 73, 421-424[Medline] [Order article via Infotrieve] |
13. | Isaacs, N. W. (1995) Curr. Opin. Struct. Biol. 5, 391-395[CrossRef][Medline] [Order article via Infotrieve] |
14. |
Pallaghy, P. K.,
Nielsen, K. J.,
Craik, D. J.,
and Norton, R. S.
(1994)
Protein Sci.
3,
1833-1839 |
15. | Craik, D. J., Daly, N. L., and Waine, C. (2001) Toxicon 39, 43-60[CrossRef][Medline] [Order article via Infotrieve] |
16. | Hernandez, J. F., Gagnon, J., Chiche, L., Nguyen, T. M., Andrieu, J. P., Heitz, A., Trinh Hong, T., Pham, T. T., and Le Nguyen, D. (2000) Biochemistry 39, 5722-30[CrossRef][Medline] [Order article via Infotrieve] |
17. | Luckett, S., Garcia, R. S., Barker, J. J., Konarev, A. V., Shewry, P. R., Clarke, A. R., and Brady, R. L. (1999) J. Mol. Biol. 290, 525-33[CrossRef][Medline] [Order article via Infotrieve] |
18. | Gran, L., Sandberg, F., and Sletten, K. (2000) J. Ethnopharmacol. 70, 197-203[CrossRef][Medline] [Order article via Infotrieve] |
19. | Craik, D. J., Daly, N. L., and Nielsen, K. J. (2000) PCT Int. Patent Appl. 43 pp WO 0015654 |
20. | Eccles, C., Guntert, P., Billeter, M., and Wüthrich, K. (1991) J. Biomol. NMR 1, 111-130[Medline] [Order article via Infotrieve] |
21. | Guntert, P., Mumenthaler, C., and Wüthrich, K. (1997) J. Mol. Biol. 273, 283-298[CrossRef][Medline] [Order article via Infotrieve] |
22. | Rice, L. M., and Brünger, A. T. (1994) Proteins 19, 277-290[Medline] [Order article via Infotrieve] |
23. | Stein, E. G., Rice, L. M., and Brünger, A. T. (1997) J. Magn. Reson. 124, 154-164[CrossRef][Medline] [Order article via Infotrieve] |
24. | Brünger, A. T. (1996) X-PLOR Manual Version 3.851 , Yale University, New Haven, CT |
25. | Clore, G. M., Brünger, A. T., Karplus, M., and Gronenborn, A. M. (1986) J. Mol. Biol. 191, 523-551[Medline] [Order article via Infotrieve] |
26. | Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., and Karplus, M. (1983) J. Comput. Chem. 4, 187-217 |
27. |
Hutchinson, E. G.,
and Thornton, J. M.
(1996)
Protein Sci.
5,
212-220 |
28. | Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R., and Thornton, J. M. (1996) J. Biomol. NMR 8, 477-486[Medline] [Order article via Infotrieve] |
29. | Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids , Wiley-Interscience, New York |
30. | Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., and Sykes, B. D. (1995) J. Biomol. NMR 5, 67-81[Medline] [Order article via Infotrieve] |
31. | Holak, T. A., Gondol, D., Otlewski, J., and Wilusz, T. (1989) J. Mol. Biol. 210, 635-648[Medline] [Order article via Infotrieve] |
32. |
Daly, N. L.,
and Craik, D. J.
(2000)
J. Biol. Chem.
275,
19068-19075 |
33. | Heitz, A., Chiche, L., Le-Nguyen, D., and Castro, B. (1989) Biochemistry 28, 2392-2398[Medline] [Order article via Infotrieve] |
34. |
Ling, M. H.,
Qi, H. Y.,
and Chi, C. W.
(1993)
J. Biol. Chem.
268,
810-814 |
35. |
Scott, C. P.,
Abel-Santos, E.,
Wall, M.,
Wahnon, D. C.,
and Benkovic, S. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13638-13643 |
36. | Paulus, H. (2000) Annu. Rev. Biochem. 69, 447-496[CrossRef][Medline] [Order article via Infotrieve] |
37. |
Evans, T. C., Jr.,
Benner, J.,
and Xu, M. Q.
(1999)
J. Biol. Chem.
274,
18359-18363 |
38. | Iwai, H., and Pluckthun, A. (1999) FEBS Lett. 459, 166-172[CrossRef][Medline] [Order article via Infotrieve] |
39. | Koradi, R., Billeter, M., and Wüthrich, K. (1996) J. Mol. Graph. 14, 51-5[CrossRef][Medline] [Order article via Infotrieve]., 29-32 |
40. | Huang, Q., Liu, S., and Tang, Y. (1993) J. Mol. Biol. 229, 1022-1036[CrossRef][Medline] [Order article via Infotrieve] |
41. | Bode, W., Greyling, H. J., Huber, R., Otlewski, J., and Wilusz, T. (1989) FEBS Lett. 242, 285-292[CrossRef][Medline] [Order article via Infotrieve] |
42. | Helland, R., Berglund, G. I., Otlewski, J., Apostoluk, W., Andersen, O. A., Willassen, N. P., and Smalas, A. O. (1999) Acta Crystallogr. D Biol. Crystallogr. 55, 139-148[CrossRef][Medline] [Order article via Infotrieve] |
43. | Di Marco, S., and Priestle, J. P. (1997) Structure 5, 1465-1474[Medline] [Order article via Infotrieve] |